Navigation Links
Lilly Reports Third-Quarter 2011 Results
Date:10/20/2011

als, Inc. and Alkermes, Inc., submitted a reply to a complete response letter issued in October 2010 by FDA regarding Bydureon™, an investigational medication for type 2 diabetes. The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) action date of January 28, 2012.
  • The company submitted its reply to a complete response letter by FDA regarding Amyvid™, a molecular Positron Emission Tomography (PET) imaging agent under investigation for the detection of beta-amyloid plaque in the brains of living patients.

  • The America Invents Act was signed into law, aligning new U.S. patent laws more closely with those from other countries and improving the global competiveness of U.S. innovator companies such as Lilly. The law will provide new advantages for U.S. inventors by streamlining the application process and addressing the backlog of current applications. This new law, which transitions the U.S. from a "first-to-invent" to a "first-inventor-to-file" system, is the most significant overhaul of the U.S. patent system in 175 years.

  • Third-Quarter Reported Results

    In the third quarter of 2011, worldwide total revenue was $6.148 billion, an increase of 9 percent compared with the third quarter of 2010. This 9 percent revenue growth was comprised of increases of 4 percent in volume and 4 percent due to the impact of foreign exchange rates. Price had a negligible impact on revenue growth, reflecting the loss of U.S. patent exclusivity for Gemzar® in November 2010. Total revenue in the U.S. increased 4 percent to $3.273 billion due to higher prices and increased volume. Total revenue outside the U.S. increased 15 percent to $2.874 billion due to the positive impact of foreign exchange rates and increased volume. Third-quarter 2011 total revenue was reduced by approximately $130 million due to the impact of U.S. health care reform.

    Gross margin increased 3.1 percent to $4.810 billion in the third quarte
    '/>"/>

    SOURCE Eli Lilly and Company
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related medicine technology :

    1. Lilly Declares Fourth-Quarter 2011 Dividend
    2. Lilly Announces Changes in Senior Management
    3. Lilly Confirms Date and Conference Call for Third-Quarter 2011 Financial Results Announcement
    4. Lilly Improves Its Environmental Footprint in Business Operations and Helps Beautify Communities
    5. Eli Lilly and Company Bringing Diabetes Education Program to the Annual Legislative Conference
    6. Lilly Celebrates 17th Consecutive Year as One of Working Mother 100 Best Companies
    7. Lilly Health Channel Debuts on YouTube
    8. Boehringer Ingelheim and Lilly to Feature Type 2 Diabetes Research in Presentations at the 47th Annual Meeting of the European Association for the Study of Diabetes
    9. The American Diabetes Association and Eli Lilly and Company Encourage African Americans to Learn About Diabetes Through a Familiar Face
    10. Lilly Announces Review of Data on Long-Term Raloxifene Treatment for Postmenopausal Osteoporosis Published in Current Medical Research & Opinion
    11. U.S. Court of Appeals Affirms Validity of Lillys Strattera Patent
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/2/2014)... SAN ANTONIO , Sept. 2, 2014 /PRNewswire/ ... private medical technology company focused on innovating lifesaving ... announced the appointment of Dr. Gabriele Niederauer ... President and CEO. Following the recent closure of ... CE Mark for the Surfacer™ Inside-Out Access Catheter ...
    (Date:9/2/2014)... , Sept. 2, 2014   Veracyte, Inc. (Nasdaq: ... Anderson , president and chief executive officer, will present in ... Healthcare Unplugged Conference 2014 on Monday, September 8, 2014 at ... The live audio webcast and subsequent replay may ... Please connect to the website at least 15 minutes prior ...
    (Date:9/2/2014)... Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... its lipid franchise were highlighted in four presentations at ... Barcelona Spain . Isis has created ... effective and safe therapeutic options to treat patients with ... drug and several other drugs in clinical development designed ...
    Breaking Medicine Technology:Bluegrass Vascular Technologies Names Dr. Gabriele Niederauer President And CEO 2Veracyte to Present at the Morgan Stanley Global Healthcare Unplugged Conference 2014 2Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 2Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 3Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 4Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 5
    ... , the leading online Medical Transcription and Editing training ... NexGen Speech Recognition Editing and Medical Transcription Program. In ... MTEC is moving their curriculum to the next level. ... this important industry migration and is being provided to ...
    ... Medical Messenger , an innovative healthcare technology ... 4 is now certified to meet 2011-2012 criteria supporting ... and Reinvestment Act (ARRA) as a Complete EHR by ... record (EHR) software capable of enabling providers to meet ...
    Cached Medicine Technology:MTEC Announces Release of NexGen Speech Recognition Editing and Medical Transcription Training Program 2Medical Messenger's AstralJet V4 Receives ONC-ATCB 2011/2012 Certification 2
    (Date:9/2/2014)... September 02, 2014 ZAMST, a leader ... endorsement deal with professional baseball star Nolan Arenado ... best young baseball players, Arenado will be working with ... specific product category. , Arenado was selected by ... #59 overall. In 2013, Arenado was awarded the Gold ...
    (Date:9/2/2014)... Kicking blog MichaelHusted.com is featuring ... on his role as a kicking coach, his kicking business, ... according to retired NFL kicker Michael Husted author of HustedKicking.com. ... and is one of the top pro free agent kickers ... with Anthony at our 2014 Pro Camp and I was ...
    (Date:9/2/2014)... 2014: Health structures explain nearly 20% of the ... results of a joint ESC-OECD study presented today ... variables explained more than 80% of non-adherence. , ... which combines clinical data and health structure characteristics ... of the reasons some patients with heart failure ...
    (Date:9/2/2014)... (PRWEB) September 02, 2014 NOVAtime ... Management solution development company, announced today that Avon ... 2009, has upgraded to NOVAtime 4000 Time ... conjunction with NOVAtime’s latest smart clock, the ... Farmington Valley of Connecticut is an award-winning nursing ...
    (Date:9/2/2014)... New York, NY (PRWEB) September 02, 2014 ... for women are long gone. But even though men shave ... an unhealthy appearance – rough and irritated skin isn’t inevitable, ... Advanced Dermatology P.C. , For decades, skin care ... years have witnessed a surge in men of all ages ...
    Breaking Medicine News(10 mins):Health News:Gold Glove Baseball Star Nolan Arenado Signs With Zamst 2Health News:MichaelHusted.com Features Interview with Anthony Cantele of Cantele Kicking on His Role as a Kicking Coach and on Becoming a National Camp Series (NCS) Associate 2Health News:MichaelHusted.com Features Interview with Anthony Cantele of Cantele Kicking on His Role as a Kicking Coach and on Becoming a National Camp Series (NCS) Associate 3Health News:Health structures explain nearly 20 percent of non-adherence to heart failure guidelines 2Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 2Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 3Health News:Rough Isn’t Rugged in Men’s Skin: Dermatology specialist Dr. Joshua Fox with Advanced Dermatology PC offers tips on easy skin maintenance for men 2Health News:Rough Isn’t Rugged in Men’s Skin: Dermatology specialist Dr. Joshua Fox with Advanced Dermatology PC offers tips on easy skin maintenance for men 3
    ... -- There are major differences between oncologists and primary ... care for American,s 12 million cancer survivors. That ... survey of doctors that reveals how these differences pose ... following initial cancer treatment. The study, published online ...
    ... When looking at a picture of many trees, young people ... we get, the more likely we are to notice a single ... which the brain processes the bigger picture is slower in older ... Elseviers Cortex , researchers have found that these age-related changes ...
    ... , SUNDAY, July 24 (HealthDay News) -- Young children ... so parents should be especially vigilant monitoring their kids around ... Centre of The Montreal Children,s Hospital also warned that toddlers ... to recognize potential dangers at a pool. Mandatory fencing ...
    ... By Steven Reinberg HealthDay Reporter , SUNDAY, July ... a new anti-clotting drug, Eliquis, to dual antiplatelet therapy may ... attack and stroke, a new study finds. A trial ... of severe bleeding among those taking Eliquis (apixaban) became apparent. ...
    ... HealthDay Reporter , FRIDAY, July 22 (HealthDay News) ... difficulty understanding medical information, your health may be at risk. ... that low health literacy is linked with many types of ... "There are no real surprises here," said study author Nancy ...
    ... News) -- Eager young athletes will be taking to sports ... to be protected from heat exhaustion and heat stroke, a ... safe is "hydration, hydration, hydration," Dr. Toni Salvatore, medical director ... in a hospital news release. Drinking adequate amounts of ...
    Cached Medicine News:Health News:Study: Doctors differ in how best to care for America's 12 million cancer survivors 2Health News:Study: Doctors differ in how best to care for America's 12 million cancer survivors 3Health News:Older people find it harder to see the wood for the trees 2Health News:Anti-Clotting Drug May Cause Severe Bleeding With No Benefit 2Health News:Anti-Clotting Drug May Cause Severe Bleeding With No Benefit 3Health News:Low 'Health Literacy' Hazardous to Your Health 2
    ... CONMED's family of products allows you to ... generators feature proprietary Energy Synchronous Processing Technology. ... current and voltage in all operational modes. ... to sample current and voltage over 450,000 ...
    ... achieves a secure clot, targeted to the ... hemostasis is needed, when control of bleeding ... and cautery, is ineffective or impractical., CROSSEAL* ... of human Biologically Active Component (BAC) and ...
    GluStitch® is indicated for the closure of uncomplicated skin lacerations where there is little or no tissue loss....
    ... pacemaker family offers some ... automatic devices. Featuring the ... advanced technologies ever seen, ... incorporates the exclusive ventricular ...
    Medicine Products: